Effects of commonly used antidiabetic drugs on antioxidant enzymes and liver function test markers in type 2 diabetes mellitus subjects - pilot study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2015-07-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0035-1554654PMID 26216367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats

  2016cited by this paper
• Correlation of Waist-to-hip Ratio (WHR) and Oxidative Stress in Patients of Acute Myocardial Infarction (AMI).

  2014cited by this paper
• Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.

  2014cited by this paper
• Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: desirable side-effects of antidiabetic drugs.

  2014cited by this paper
• Oxidative stress and liver disease

  2012cited by this paper
• NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

  2012cited by this paper
• Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in rats.

  2012cited by this paper
• Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease

  2010cited by this paper
• Statins in liver disease: A molehill, an iceberg, or neither?

  2008cited by this paper
• Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.

  2008cited by this paper
• Insulin sensitivity: modulation by nutrients and inflammation.

  2008cited by this paper
• Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.

  2008cited by this paper
• Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2‐h plasma glucose concentrations

  2007cited by this paper
• Impact of diabetes on the severity of liver disease.

  2007cited by this paper
• Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

  2006cited by this paper
• Sex and Racial Differences in Pharmacological Response: Where Is the Evidence? Pharmacogenetics, Pharmacokinetics, and Pharmacodynamics

  2005cited by this paper
• Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.

  2004cited by this paper
• Use and abuse of HOMA modeling.

  2004cited by this paper
• Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.

  2003cited by this paper
• Antioxidant enzymes activity in patients with peripheral vascular disease, with and without presence of diabetes mellitus.

  2003cited by this paper
• Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA

  2003cited by this paper
• Endothelial dysfunction: clinical strategies for treating oxidant stress.

  2003cited by this paper
• An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress.

  2003cited by this paper
• Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo

  2002cited by this paper
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control.

  2001cited by this paper
• Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity

  2000cited by this paper
• Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

  2000cited by this paper
• An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

  1999cited by this paper
• Serum interleukin-8 level is increased in diabetic patients

  1999cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

  1991cited by this paper
• Correlates of Diabetes Markers with Erythrocytic Enzymes Decomposing Reactive Oxygen Species

  1988cited by this paper

• Possible biochemical markers-predictors of severe course of infectious diseases in patients with type 2 diabetes mellitus

  2024cites this paper
• Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus

  2020cites this paper
• Gender dependent effects of fasting blood glucose levels and disease duration on biochemical markers in type 2 diabetics: A pilot study.

  2017cites this paper
• Hypoglycemic drugs induce antioxidant aldehyde dehydrogenase activity and remain high in patients with glycemic control in type 2 diabetes

  2017cites this paper
• Glutathione and Malondialdehyde levels in the serum of type 2 diabetes mellitus with coronary heart disease

  2016cites this paper
• Does bilirubin protect against developing diabetes mellitus?

  2016cites this paper
• Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats

  2016cites this paper